Patents by Inventor Jacob Kaizerman

Jacob Kaizerman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060116326
    Abstract: Benzothiophene compounds such as are DNA binding compounds exhibiting antibacterial activity.
    Type: Application
    Filed: November 30, 2004
    Publication date: June 1, 2006
    Applicant: GeneSoft Pharmaceuticals, Inc.
    Inventors: Roland Burli, Eldon Baird, Matthew Taylor, Jacob Kaizerman, Wenhao Hu
  • Publication number: 20060069034
    Abstract: Antipathogenic benzamide compounds having the formula wherein at least one of the R1 groups is F, Cl, CN or CF3 and R2, R3, Y, Z, m, and n are as defined herein.
    Type: Application
    Filed: December 2, 2004
    Publication date: March 30, 2006
    Applicant: GeneSoft Pharmaceuticals, Inc.
    Inventors: Roland Burli, Jacob Kaizerman, Peter Jones
  • Patent number: 6825228
    Abstract: Benzothiophene compounds such as are DNA binding compounds exhibiting antibacterial activity.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: November 30, 2004
    Assignee: Genesoft Pharmaceuticals, Inc.
    Inventors: Roland W. Bürli, Eldon E. Baird, Matthew J. Taylor, Jacob A. Kaizerman, Wenhao Hu
  • Patent number: 6794437
    Abstract: This invention is of a hybrid organoclay that consists of an organic chemical/phyllosilicate clay intercalate that has been ion-exchanged with quaternary ammonium compounds. Since this hybrid organoclay is hydrophobic, it can be washed in water to remove reaction salts and excess water soluble or water dispersible polymers to give a clean product via inexpensive means such as filtration. This allows a better dispersing composition to be prepared without the difficulties of isolation presented by prior art which uses energy intensive means to remove the bulk of the water from the final product and cannot be easily washed. In one aspect, the present invention provides a solid clay/chemical composition that comprises: (a) one or more smectite clays, (b) a quaternary ammonium compound which reacts via an ion exchange mechanism with the smectite clay, and (c) one or more non-anionic organic materials that intercalate with the clay.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: September 21, 2004
    Assignee: Elementis Specialties, Inc.
    Inventors: Mark Ross, Jacob Kaizerman
  • Patent number: 6777425
    Abstract: Isoquinoline compounds having the formula where R1, R2, Y, m, n, and Z are as defined herein, bind to the minor groove of DNA and have antifungal and antibacterial activity.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: August 17, 2004
    Assignee: Genesoft Pharmaceuticals, Inc.
    Inventors: Roland W. Bürli, Peter Jones, Jacob A. Kaizerman, Wenhao Hu
  • Publication number: 20040142971
    Abstract: Benzothiophene compounds such as 1
    Type: Application
    Filed: June 6, 2002
    Publication date: July 22, 2004
    Applicant: GeneSoft, Inc.
    Inventors: Roland W. Burli, Eldon E. Baird, Matthew J. Taylor, Jacob A. Kaizerman, Wenhao Hu
  • Publication number: 20040087700
    Abstract: This invention is of a hybrid organoclay that consists of an organic chemical/phyllosilicate clay intercalate that has been ion-exchanged with quaternary ammonium compounds. Since this hybrid organoclay is hydrophobic, it can be washed in water to remove reaction salts and excess water soluble or water dispersible polymers to give a clean product via inexpensive means such as filtration. This allows a better dispersing composition to be prepared without the difficulties of isolation presented by prior art which uses energy intensive means to remove the bulk of the water from the final product and cannot be easily washed.
    Type: Application
    Filed: December 14, 2001
    Publication date: May 6, 2004
    Applicant: Rheox, Inc.
    Inventors: Mark Ross, Jacob Kaizerman
  • Patent number: 6716866
    Abstract: Aryl-benzimidazole compounds according to the formula where Ar1, R1, R2, Y, W, and N are as defined herein, bind to DNA and have antibacterial activity.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: April 6, 2004
    Assignee: GeneSoft Pharmaceuticals, Inc.
    Inventors: Dustin L. McMinn, Roland W. Bürli, Jacob Kaizerman, Eldon E. Baird, Matthew J. Taylor
  • Publication number: 20030236198
    Abstract: Antipathogenic benzamide compounds having the formula 1
    Type: Application
    Filed: June 6, 2002
    Publication date: December 25, 2003
    Applicant: GeneSoft, Inc.
    Inventors: Roland W. Burli, Jacob A. Kaizerman, Peter Jones
  • Publication number: 20030191168
    Abstract: Aryl-benzimidazole compounds according to the formula 1
    Type: Application
    Filed: June 6, 2002
    Publication date: October 9, 2003
    Applicant: GeneSoft, Inc.
    Inventors: Dustin L. McMinn, Roland W. Burli, Jacob Kaizerman, Eldon E. Baird, Matthew J. Taylor
  • Patent number: 6610770
    Abstract: The present invention is directed to polymer compositions with flame retardant properties that are made from a polymer blended using a defined process with a smectite clay that has been reacted with a specified mixture of organic materials. The inventive compositions have the property that when the organically modified clay is added to the polymer, a composite results which has flame-retardant properties and is based on the finding that degree of dispersion of a smectite organoclay in a polymer matrix will give the compositions flame-retardant properties. Further, it has been found that it is very important to proper functioning of the flame retardant polymer compositions that they have the organoclay dispersed in the polymer such that it is not completely exfoliated.
    Type: Grant
    Filed: October 4, 1999
    Date of Patent: August 26, 2003
    Assignee: Elementis Specialties, Inc.
    Inventors: Mark Ross, Jacob Kaizerman
  • Publication number: 20030130198
    Abstract: Halogen substituted thienyl compounds exhibit potential as nucleic acid (especially double stranded DNA) binders and as antibiotic compounds.
    Type: Application
    Filed: April 24, 2002
    Publication date: July 10, 2003
    Applicant: GeneSoft, Inc.
    Inventors: Yigong Ge, Matthew J. Taylor, Eldon E. Baird, Roland W. Burli, Jacob A. Kaizerman, Amanda E. Martin, Brie Cadman
  • Publication number: 20030083268
    Abstract: Isoquinoline compounds having the formula 1
    Type: Application
    Filed: June 6, 2002
    Publication date: May 1, 2003
    Applicant: GeneSoft, Inc.
    Inventors: Roland W. Burli, Peter Jones, Jacob A. Kaizerman, Wenhao Hu
  • Patent number: 6521690
    Abstract: This invention is of a composition comprised of a smectite clay modified with an organic chemical composition and a polymer. The composition consists of an organic chemical/smectite clay intercalate that has been ion-exchanged and reacted and intercalated with one or more quarternary ammonium compounds and an anionic material and further blended into a polymer resin to make a nanocomposite composition. This material can be blended into a wide variety of polymers. This kind of system gives improved dispersion over conventional organoclays, intercalates or hybrid clays described in the literature, especially in non-polar resins. The defined organoclay has been found to be highly dispersible in a variety of polymers, whether polar or non-polar.
    Type: Grant
    Filed: May 25, 1999
    Date of Patent: February 18, 2003
    Assignee: Elementis Specialties, Inc.
    Inventors: Mark Ross, Jacob Kaizerman
  • Patent number: 6380295
    Abstract: This invention is of a hybrid organoclay that consists of an organic chemical/phyllosilicate clay intercalate that has been ion-exchanged with quaternary ammonium compounds. Since this hybrid organoclay is hydrophobic, it can be washed in water to remove reaction salts and excess water soluble or water dispersible polymers to give a clean product via inexpensive means such as filtration. This allows a better dispersing composition to be prepared without the difficulties of isolation presented by prior art which uses energy intensive means to remove the bulk of the water from the final product and cannot be easily washed. In one aspect, the present invention provides a solid clay/chemical composition that comprises: (a) one or more smectite clays, (b) a quaternary ammonium compound which reacts via an ion exchange mechanism with the smectite clay, and (c) one or more non-anionic organic materials that intercalate with the clay.
    Type: Grant
    Filed: April 22, 1998
    Date of Patent: April 30, 2002
    Assignee: Rheox Inc.
    Inventors: Mark Ross, Jacob Kaizerman